These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30323617)

  • 1. H19 induced by oxidative stress confers temozolomide resistance in human glioma cells via activating NF-κB signaling.
    Duan S; Li M; Wang Z; Wang L; Liu Y
    Onco Targets Ther; 2018; 11():6395-6404. PubMed ID: 30323617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy.
    Jiang P; Wang P; Sun X; Yuan Z; Zhan R; Ma X; Li W
    Onco Targets Ther; 2016; 9():3501-9. PubMed ID: 27366087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma.
    Xu JX; Yang Y; Zhang X; Luan XP
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1922-1931. PubMed ID: 32141561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/β-Catenin pathway.
    Jia L; Tian Y; Chen Y; Zhang G
    Onco Targets Ther; 2018; 11():313-321. PubMed ID: 29391808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms for hypoxia
    Zhao H; Meng L; Liao X; Liu Y; Mo X; Gong M; Liao Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 47(7):829-838. PubMed ID: 36039578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C; Feng S; Chen L
    Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of lncRNA IRAIN restrains the progression and Temozolomide resistance of glioma via repressing IGF-1R-PI3K-NF-κB signaling pathway.
    Guo A; Fang G; Lin Z; Zheng S; Zhuang Z; Lin R; Lin Y
    Histol Histopathol; 2022 Jun; 37(6):543-554. PubMed ID: 35102541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-κB inhibitor reverses temozolomide resistance in human glioma TR/U251 cells.
    Wang X; Jia L; Jin X; Liu Q; Cao W; Gao X; Yang M; Sun B
    Oncol Lett; 2015 Jun; 9(6):2586-2590. PubMed ID: 26137111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BKM120 sensitizes C6 glioma cells to temozolomide via suppression of the PI3K/Akt/NF-κB/MGMT signaling pathway.
    Li M; Liang RF; Wang X; Mao Q; Liu YH
    Oncol Lett; 2017 Dec; 14(6):6597-6603. PubMed ID: 29151909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomic analysis identifies the neuropeptide cortistatin (CORT) as an inhibitor of temozolomide (TMZ) resistance by suppressing the NF-κB-MGMT signaling axis in human glioma.
    He Z; Peng B; Wang Q; Tian J; Liu P; Feng J; Liao Y; Chen L; Jia P; Tang J
    Genes Dis; 2024 May; 11(3):100977. PubMed ID: 38292193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/
    Chen M; Cheng Y; Yuan Z; Wang F; Yang L; Zhao H
    Cancer Biother Radiopharm; 2020 Mar; 35(2):101-108. PubMed ID: 31750728
    [No Abstract]   [Full Text] [Related]  

  • 12. Circ-VPS18 Knockdown Enhances TMZ Sensitivity and Inhibits Glioma Progression by MiR-370/RUNX1 Axis.
    Li W; Ma Q; Liu Q; Yan P; Wang X; Jia X
    J Mol Neurosci; 2021 Jun; 71(6):1234-1244. PubMed ID: 33188501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of RIP2 enhancing stemness of glioma cells induces temozolomide resistance.
    Wang XL; Jiao BH; Wu JL; Yang JK; Hu YH; Cui K
    CNS Neurosci Ther; 2022 Dec; 28(12):2319-2330. PubMed ID: 36184801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA KCNQ1OT1 Confers Gliomas Resistance to Temozolomide and Enhances Cell Growth by Retrieving PIM1 From miR-761.
    Wang W; Han S; Gao W; Feng Y; Li K; Wu D
    Cell Mol Neurobiol; 2022 Apr; 42(3):695-708. PubMed ID: 32897512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA LIFR-AS1 suppresses proliferation, migration and invasion and promotes apoptosis through modulating miR-4262/NF-κB pathway in glioma.
    Ding H; Cui L; Wang C
    Neurol Res; 2021 Mar; 43(3):210-219. PubMed ID: 33070767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
    Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
    Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD147 confers temozolomide resistance of glioma cells via the regulation of β-TrCP/Nrf2 pathway.
    Bu X; Qu X; Guo K; Meng X; Yang X; Huang Q; Dou W; Feng L; Wei X; Gao J; Sun W; Chao M; Han L; Hu Y; Shen L; Zhang J; Wang L
    Int J Biol Sci; 2021; 17(12):3013-3023. PubMed ID: 34421346
    [No Abstract]   [Full Text] [Related]  

  • 18. Heparanase confers temozolomide resistance by regulation of exosome secretion and circular RNA composition in glioma.
    Si J; Li W; Li X; Cao L; Chen Z; Jiang Z
    Cancer Sci; 2021 Sep; 112(9):3491-3506. PubMed ID: 34036683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicoRNA-214-3p: a key player in CPLX2-mediated inhibition on temozolomide resistance in glioma.
    Peng Q; Wang L; Wang S; Wang C; Xue Z
    Neurol Res; 2022 Oct; 44(10):879-887. PubMed ID: 36117461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway.
    Tang Q; Cao H; Tong N; Liu Y; Wang W; Zou Y; Xu L; Zeng Z; Xu W; Yin Z; Ma W; Wang Q
    Phytomedicine; 2022 May; 99():154016. PubMed ID: 35278900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.